Drugs for Reactive Arthritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 42)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Azithromycin |
Approved |
Phase 3 |
|
83905-01-5 |
447043 |
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
Azadose
AZASITE
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
AZITHROMYCIN
AZITHROMYCIN ANHYDROUS
Azithromycin dihydrate
AZITHROMYCIN HYDRATE
Azithromycin monohydrate
Azithromycin pfizer brand
Azithromycine
Azithromycinum
Azitrocin
Azitromicina
Azitromin
AZYTER
Azythromycin
Bayer brand OF azithromycin dihydrate
CLAMELLE
CP 62993
|
CP-62,993
CP-62993
Dihydrate, azithromycin
Funk brand OF azithromycin dihydrate
Goxal
Hemomycin
Lesvi brand OF azithromycin dihydrate
Mack brand OF azithromycin dihydrate
Monohydrate, azithromycin
Pfizer brand OF azithromycin
Pfizer brand OF azithromycin dihydrate
Pharmacia brand OF azithromycin dihydrate
Sumamed
SUNAMED
Toraseptol
Ultreon
Vinzam
Vita brand OF azithromycin dihydrate
XZ 405
XZ 450
XZ-450
Zentavion
Zithromax
Zitromax
Zmax
|
|
2 |
|
Rifampicin |
Approved |
Phase 3 |
|
13292-46-1 |
135512673 5381226 135900090 |
Synonyms:
2,15,17,23,27,29-Hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{[(4-methylpiperazin-1-yl)imino]methyl}-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1,.0,]triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetic acid
3-(((4-METHYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN SV
Archidyn
BA-411661E
BA-41166E
Benemycin
EREMFAT
L-5103
L-5103 Lepetit
L-5103-LEPETIT
NIH-10782
NSC-113926
R/AMP
RAMP
Rfamipicin
RFP
Rifa
Rifadin
Rifadin IV
Rifadin®|rifampin
Rifadine
Rifagen
|
Rifaldazin
Rifaldazine
Rifaldin
RIFAMPICIN
Rifampicin SV
Rifampicina
Rifampicine
Rifampicinum
Rifampin
Rifamycin
RIFAMYCIN AMP
Rifaprodin
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactin
Rimazid
Rofact
Tubocin
|
|
3 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 3 |
|
564-25-0 |
54671203 |
Synonyms:
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
5-Hydroxy-a-6-deoxytetracycline
5-Hydroxy-alpha-6-deoxytetracycline
5-Hydroxy-α-6-deoxytetracycline
6a-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6Α-deoxy-5-oxytetracycline
Anhydrous doxycycline
BMY-28689|Monodox®|Vibramycin®
Doxcycline anhydrous
Doxiciclina
DOXY
Doxychel
Doxycyclin
Doxycycline
|
Doxycycline (anhydrous)
DOXYCYCLINE ANHYDROUS
DOXYCYCLINE HCL
Doxycycline hyclate
Doxycycline hydrate
Doxycycline hydric acid
Doxycycline monohydrate
Doxycycline monohydric acid
Doxycyclinum
Doxytetracycline
GS-3065
Jenacyclin
Monodox
Oracea
Supracyclin
Vibramycin
|
|
4 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
5 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
6 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
7 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
8 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
9 |
|
Antimalarials |
|
Phase 3 |
|
|
|
10 |
|
Antitubercular Agents |
|
Phase 3 |
|
|
|
11 |
|
Infliximab |
Approved |
Phase 2 |
|
170277-31-3 |
|
Synonyms:
ABP 710
BOW015
CA2
CA2 ????
IG GAMMA-1 CHAIN C REGION
INFLECTRA
INFLIXIMAB
Infliximab (genetical recombination)
|
Infliximab-abda
Infliximab-axxq
Infliximab-dyyb
Infliximab-qbtx
NI-071
REMICADE
REMSIMA
TA-650
|
|
12 |
|
Licorice |
Approved |
Phase 1, Phase 2 |
|
|
|
Synonyms:
|
13 |
|
Turmeric |
Approved, Experimental, Investigational |
Phase 1, Phase 2 |
|
|
|
Synonyms:
Ae-turmeric
Allergenic Extract- Turmeric Curcuma Longa
Amomum Curcuma Root
Constrained Metal (Curcuma Longa)
Curcuma Brog Root
Curcuma Domestica Extract
Curcuma Domestica Root
Curcuma Euchroma Root
Curcuma Longa
Curcuma Longa (Turmeric) Rhizome Extract
Curcuma Longa (Turmeric) Root
Curcuma Longa (Turmeric) Root Extract
Curcuma Longa (Turmeric) Root Powder
Curcuma Longa Extract
Curcuma Longa Rhizome
Curcuma Longa Rhizome Extract
Curcuma Longa Root
Curcuma Longa Root Dry Extract
Curcuma Longa Root Extract
Curcuma Longa Root Tuber
Curcuma Montana Root
Curcuma Ochrorhiza Root
Curcuma Soloensis Root
Curcuma Viridiflora Root
Curcumae Longae Rhizoma
Curcumae Longae Rhizoma (Cucuma Longa)
Curcumae Longae Rhizoma (Curcuma Longa)
Curcumae Radix (Curcuma Longa)
|
Curcumae Rhizoma (Curcuma Longa)
Curcumarum Tuber Et Radix (Curcuma Longa)
Ginger Yellow (Curcuma Longa)
Guiyujin (Curcuma Longa)
Haldi Root
Haridra Root
Huangsiyujin (Cucuma Longa)
Indian Saffron Root
Jiang Huang (Curcuma Longa)
Jianghuang
Kua Domestica Root
Lusiyujin (Curcuma Longa)
Spices, Turmeric, Ground
Stissera Curcuma Root
Stissera Longa Root
Turmeric Extract
Turmeric Rhizome (Curcuma Longa)
Turmeric Root
Turmeric Root Extract
Turmeric Root Powder
Turmeric Root Tuber (Curcuma Longa)
Turmeric Tuber (Curcuma Longa)
Turmeric,ground
Wunyujin (Cucuma Longa)
Yellow Ginger Root
Yu Jin
Yujin (Curcuma Longa)
|
|
14 |
|
Glycerin |
Approved, Investigational |
Phase 2 |
|
56-81-5 |
753 |
Synonyms:
(2,5-Dihydroxyphenyl)-acetate
(2,5-Dihydroxyphenyl)-acetic acid
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
1,2,3-Propanetriol
1,2,3-Trihydroxypropane
2-(3,6-DIHYDROXYPHENYL)acetate
2-(3,6-DIHYDROXYPHENYL)acetIC ACID
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2,5-Dihydroxy-alpha-toluate
2,5-Dihydroxy-alpha-toluic acid
2,5-Dihydroxy-a-toluate
2,5-Dihydroxy-a-toluic acid
2,5-Dihydroxy-benzeneacetate
2,5-Dihydroxy-benzeneacetic acid
2,5-Dihydroxyphenylacetate
2,5-Dihydroxyphenylacetic acid
Acid, homogentisic
Alcapton
Allomaleate
Allomaleic acid
alpha-delta-Glucopyranuronic acid
alpha-delta-Glucuronic acid
alpha-D-Glucopyranuronic acid
alpha-D-Glucuronic acid
Ammonium fumarate
Boletate
Boletic acid
Bulbold
Concentrated glycerin
Cristal
D-(+)-Glucuronate
D-(+)-Glucuronic acid
delta-(+)-Glucuronate
delta-(+)-Glucuronic acid
delta-Glucuronate
D-Glucuronate
e 422
e297
Emery 916
FC 33
Fumarate
Fumarsaeure
Furamag
GCU
GlcAa
GlcAalpha
|
Glucosiduronate
Glucosiduronic acid
Glucuronate
Glucuronic acid
Glyceol opthalgan
Glycerin
Glycerin, anhydrous
Glycerin, concentrated
Glycerin,anhydrous
Glycerine
glycérine
Glycerinum
Glyceritol
Glycerol
glycérol
Glycerolum
Glycyl alcohol
Glyrol
Glysanin
Glyzerin
Gro
Homogentisate
Homogentisate acid
Homogentisinate
Homogentisinic acid
IFP
Incorporation factor
Lichenate
Lichenic acid
Mackstat H 66
Mafusol
Magnesium fumarate
Melanic acid
Monoctanoin component D
Oelsuess
Ölsüß
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Sodium fumarate
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
Trihydroxypropane
Tryhydroxypropane
|
|
15 |
|
Gastrointestinal Agents |
|
Phase 2 |
|
|
|
16 |
|
Antiviral Agents |
|
Phase 2 |
|
|
|
17 |
|
Antirheumatic Agents |
|
Phase 2 |
|
|
|
18 |
|
interferons |
|
Phase 2 |
|
|
|
19 |
|
Interferon-gamma |
|
Phase 2 |
|
|
|
20 |
|
Tumor Necrosis Factor Inhibitors |
|
Phase 2 |
|
|
|
21 |
|
Dermatologic Agents |
|
Phase 2 |
|
|
|
22 |
|
Astragalus |
|
Phase 1, Phase 2 |
|
|
|
23 |
|
Skullcap |
|
Phase 1, Phase 2 |
|
|
|
24 |
|
Turmeric extract |
|
Phase 1, Phase 2 |
|
|
|
25 |
|
Hawthorn |
|
Phase 1, Phase 2 |
|
|
|
26 |
|
Chinese Yam |
|
Phase 1, Phase 2 |
|
|
|
27 |
|
Chinese Salvia |
|
Phase 1, Phase 2 |
|
|
|
28 |
|
Chinese Rhubarb |
|
Phase 1, Phase 2 |
|
|
|
29 |
|
Vaccines |
|
Phase 1 |
|
|
|
30 |
|
Rifaximin |
Approved, Investigational |
|
|
80621-81-4 |
46783403 6436173 |
Synonyms:
(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,23,36-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6-oxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1,.0,.0,.0,]heptatriaconta-1(35),2,4,9,19,21,23,25(36),26(34),28,30,32-dodecaen-13-yl acetic acid
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
NORMIX
Redactiv
RIFACOL
RIFAMYCIN L 105
RIFAMYCIN L 105SV
RIFAXIDIN
Rifaximin
|
RIFAXIMINA
RIFAXIMINE
RIFAXIMINUM
RIFAXIMINUN
TARGAXAN
Xifaxan
XIFAXANTA
XIFAXSAN
|
|
31 |
|
Levofloxacin |
Approved, Investigational |
|
|
100986-85-4 |
149096 |
Synonyms:
(-)-Ofloxacin
(2S)-7-FLUORO-2-METHYL-6-(4-METHYLPIPERAZIN-1-YL)-10-OXO-4-OXA-1-AZATRICYCLO[7.3.1.0^{5,13}]TRIDECA-5(13),6,8,11-TETRAENE-11-CARBOXYLIC ACID
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
Anhydrous, levofloxacin
Cravit
DR-3355
EVOXIL
FLOXACIN
Floxin
IQUIX
Levaquin
|
LEVOFLOXACIN
Levofloxacin anhydrous
LEVOFLOXACIN HEMIHYDRATE
Levofloxacin hydrate
Levofloxacine
Levofloxacino
Levofloxacinum
L-Ofloxacin
Ofloxacin
Ofloxacin S-(-)-form
OFLOXACIN S-(-)-FORM HEMIHYDRATE
Ofloxacin, (S)-isomer
OFTAQUIX
QUINSAIR
Quixin
RWJ-25213
TAVANIC
|
|
32 |
|
Ofloxacin |
Approved |
|
|
82419-36-1 |
4583 |
Synonyms:
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
Akilen
Baccidal
Bactocin
Danoflox
DL-8280
Effexin
EXOCIN
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
FLOXIN OTIC
Floxstat
Fugacin
Hoe 280
Hoe-280
Inoflox
J01MA01
Kinflocin
Kinoxacin
Liflox
Loxinter
Marfloxacin
Medofloxine
Mergexin
Novecin
Nufafloqo
Obide
Occidal
OCUFLOX
Ofcin
Oflin
Oflocee
Oflocet
|
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
OFLOXACIN
Ofloxacin hydrochloride
Ofloxacine
Ofloxacino
Ofloxacinum
Ofloxin
OFLX
Ofus
Onexacin
Operan
Orocin
Otonil
Pharflox
Praxin
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Sinflo
Tabrin
Taravid
Tariflox
Tarivid
TARIVID 400
TARIVID I.V.
Telbit
Tructum
Uro Tarivid
Viotisone
VISIREN
Zanocin
|
|
33 |
|
Roxithromycin |
Approved, Investigational, Withdrawn |
|
|
80214-83-1 |
6915744 |
Synonyms:
(9E)-ERYTHROMYCIN 9-(O-((2-METHOXYETHOXY)METHYL)OXIME)
1a Brand OF roxithromycin
9-[O-(2-Methoxyethoxymethyl)-oxime] OF erythromycin
Alpharma brand OF roxithromycin
Aventis brand OF roxithromycin
Basics brand OF roxithromycin
Betapharm brand OF roxithromycin
Biaxsig
Claramid
CT-Arzneimittel brand OF roxithromycin
Faes brand OF roxithromycin
Grünenthal brand OF roxithromycin
Hexal brand OF roxithromycin
Hoechst brand OF roxithromycin
Infectopharm brand OF roxithromycin
Infectoroxit
Juta brand OF roxithromycin
Knoll brand OF roxithromycin
Lichtenstein brand OF roxithromycin
Macrosil
Medeva brand OF roxithromycin
Merck dura brand OF roxithromycin
MIP brand OF roxithromycin
MTW Brand OF roxithromycin
MTW-Roxithromycin
Pfizer brand OF roxithromycin
Rotesan
Rotramin
|
Roxi 1a pharma
Roxi basics
Roxi tad
Roxi von CT
Roxibeta
Roxidura
Roxigamma
Roxigrün
Roxihexal
Roxi-paed 1a pharma
Roxi-puren
Roxi-Q
Roxi-saar
Roxithro-lich
ROXITHROMYCIN
Roxithromycin hexal brand
ROXITHROMYCINE
ROXITHROMYCINUM
ROXITROMICINA
Roxi-wolff
RU-28965
RU-965
Rulid
Rulide
Sigma brand OF roxithromycin
TAD brand OF roxithromycin
Wolff brand OF roxithromycin
Wörwag brand OF roxithromycin
|
|
34 |
|
Leflunomide |
Approved, Investigational |
|
|
75706-12-6 |
3899 |
Synonyms:
5-Methylisoxazole-4-carboxylate (4-trifluoromethyl)anilide
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
a,a,a-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
ARABLOC
Arabloc®|Arava®|HWA 486|HWA-486|lefunamide|SU-101
Arava
Aventis behring brand OF leflunomide
Aventis brand OF leflunomide
Aventis pharma brand OF leflunomide
Hoechst brand OF leflunomide
HWA 486
HWA-486
|
L04AA13
Leflunomida
LEFLUNOMIDE
Léflunomide
Leflunomidum
Leflunomidum [INN-Latin]
LEFUNAMIDE
LEFUNOMIDE
Lefunomide [INN-Spanish]
N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
SU101
SU-101
SULOL
Α,α,α-trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
|
|
35 |
|
Azathioprine |
Approved |
|
|
446-86-6 |
2265 |
Synonyms:
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
Azamun
AZAMUNE
Azanin
AZAPRESS
Azasan
Azathioprin
AZATHIOPRINE
Azathioprine sodium
Azathioprine sodium salt
Azathioprine sulfate
Azathioprinum
Azatioprin
Azatioprina
|
Azothioprine
BERKAPRINE
BW-57-322
Ccucol
IMMUNOPRIN 50
Immuran
Imuran
IMURAN (TN)
Imurek
Imurel
KENTAPRINE
Muran
NSC-39084
OPRISINE 50
Sodium, azathioprine
|
|
36 |
|
Methotrexate |
Approved |
|
|
1959-05-2, 59-05-2 |
4112 126941 |
Synonyms:
[<sup>3</sup>H]-methotrexate
2-[(4-{[(4-amino-2-imino-2,3-dihydropteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioate
4-Amino-10-methylfolate
4-Amino-10-methylfolic acid
4-Amino-N(10)-methylpteroylglutamate
4-Amino-N(10)-methylpteroylglutamic acid
ABITREXATE
Abitrexate®|amethopterin|Nordimet®|Rasuvo®
Amethopterin
Amethopterine
Antifolan
Arbitrexate
CL-14377
Dicesium salt methotrexate
EBETREX
EMT-25299
Emtexate
EMTEXATE HIGH-POT
EMTEXATE PF
Emtexic acid
FOLEX
HDMTX
Hydrate, methotrexate
L-Amethopterin
Ledertrexate
Ledertrexic acid
MAXTREX
Metatrexan
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate
Méthotrexate
Methotrexate hydrate
|
Methotrexate sodium
Methotrexate, (D)-isomer
Methotrexate, (DL)-isomer
Methotrexate, dicesium salt
Methotrexate, disodium salt
Methotrexate, sodium salt
Methotrexatum
Methotrexic acid
Methylaminopterin
Methylaminopterinum
METOJECT
Metotrexato
Mexate
MEXATE-AQ
MTX
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamate
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
N-Bismethylpteroylglutamic acid
NSC-740
Otrexup
OTREXUP PFS
R-9985
RASUVO
Rheumatrex
R-METHOTREXATE
Sodium, methotrexate
TCMDC-123832
TCMDC-125488
TCMDC-125858
TCMDC-125858TCMDC-125488TCMDC-123832Methotrexate
TCMDC-125858TCMDC-125488TCMDC-123832Methotrexic acid
Trexall
Xatmep
ZLATAL
|
|
37 |
|
Mycophenolic acid |
Approved, Investigational |
|
|
24280-93-1 |
446541 |
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
68618
Acid, mycophenolic
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Cellcept
ERL080
ERL-080
ERL-080|Myfortic® (mycophenolate sodium)
Melbex
Micofenolico acido
Mofetil hydrochloride, mycophenolate
Mofetil, mycophenolate
|
Mycophenoic acid
Mycophenolate
Mycophenolate mofetil
Mycophenolate mofetil hydrochloride
Mycophenolate sodium
Mycophenolate, sodium
MYCOPHENOLIC ACID
Mycophenolic acid morpholinoethyl ester
Mycophenolsaeure
Mycophenolsäure
Myfortic
NSC-129185
RS-61443 [AS MOFETIL]
Sodium mycophenolate
|
|
38 |
|
Sulfasalazine |
Approved |
|
|
599-79-1 |
5353980 5339 5359476 |
Synonyms:
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoate
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
2-Hydroxy-5-((4-((2-pyridinylamino)sulphonyl)phenyl)azo)benzoate
2-Hydroxy-5-((4-((2-pyridinylamino)sulphonyl)phenyl)azo)benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoate
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulphamoyl)-phenylazo]-benzoate
2-Hydroxy-5-[4-(pyridin-2-ylsulphamoyl)-phenylazo]-benzoic acid
4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
4-(Pyridyl-2-amidosulphonyl)-3'-carboxy-4'-hydroxyazobenzene
5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylate
5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-((p-(2-Pyridylsulphamoyl)phenyl)azo)salicylate
5-((p-(2-Pyridylsulphamoyl)phenyl)azo)salicylic acid
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoate
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
5-(4-(2-Pyridylsulphamoyl)phenylazo)-2-hydroxybenzoate
5-(4-(2-Pyridylsulphamoyl)phenylazo)-2-hydroxybenzoic acid
5-(p-(2-Pyridylsulfamyl)phenylazo)salicylate
5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(p-(2-Pyridylsulphamyl)phenylazo)salicylate
5-(p-(2-Pyridylsulphamyl)phenylazo)salicylic acid
Accucol
Alti-Sulfasalazine
Asulfidine
Azlufidine EN-Tabs
AZOPYRIN
Azopyrine
Azulfidine
AZULFIDINE EN
AZULFIDINE EN-TABS
Azulfidine®|Salazopyridin®|Salazopyrin®|SAS-500
Benzosulfa
COLIZINE
Colo-Pleon
NSC-203730
|
NSC-667219
PMS-Sulfasalazine
Pms-Sulfasalazine E.C.
Reupirin
Rorasul
S.A.S.
S.A.S. Enteric-500
S.A.S.-500
Salazopiridazin
SALAZOPYRIDIN
SALAZOPYRIN
SALAZOPYRIN E.C.
Salazopyrin EN-Tabs
SALAZOPYRIN-EN
Salazosulfapiridina
Salazosulfapyridin
Salazosulfapyridine
Salazosulfapyridinum
Salazosulphapiridina
Salazosulphapyridine
Salazosulphapyridinum
Salicylazosulfapyridine
Salicylazosulphapyridine
Salisulf
SAS-500
Sulcolon
Sulfasalazin
Sulfasalazina
SULFASALAZINE
Sulfasalazinum
Sulphasalazina
Sulphasalazine
Sulphasalazinum
UCINE
W-T Sasp Oral
|
|
39 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
|
|
|
|
40 |
|
Immune Checkpoint Inhibitors |
|
|
|
|
|
41 |
|
Salicylates |
|
|
|
|
|
Synonyms:
2-Hydroxybenzoate ion(1-)
2-Hydroxybenzoic acid ion(1-)
O-Hydroxybenzoate
|
O-Hydroxybenzoic acid
sal
Salicylic acid
|
|
42 |
|
Anesthetics |
|
|
|
|
|
Interventional clinical trials:
(show all 16)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis |
Completed |
NCT00351273 |
Phase 3 |
Doxycycline and Rifampin;Azithromycin and Rifampin;Placebo |
2 |
New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis: Immunostimulation Plus Antibiotic Versus Immunosuppression Plus Antibiotic Versus Conventional Standardtherapy |
Unknown status |
NCT00244179 |
Phase 2 |
interferon-gamma;infliximab;dmard |
3 |
Treating Sequalae Caused by Post-acute Sequelae of SARS (Severe Acute Respiratory Syndrome)-CoV-2 Infection |
Recruiting |
NCT04846010 |
Phase 1, Phase 2 |
|
4 |
Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatment-naïve Patients With Newly Diagnosed Rheumatoid Arthritis, Reactive Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Gouty Arthritis, Psoriasis, Hidradenitis Suppurativa, Pulmonary Sarcoidosis, Crohn's Disease, and Ulcerative Colitis: a 52-week, Double-blind, Randomised, Placebo-controlled, Exploratory Trial |
Not yet recruiting |
NCT04924270 |
Phase 2 |
|
5 |
Phase 1 Two Stage Randomized, Double-blind, Placebo Controlled Dose- and Schedule Ranging Trial to Assess the Acute Safety, Tolerability, and Immunogenicity of a Live, Attenuated Shigella/ETEC Combination Vaccine Delivered Orally to Healthy Adults Age 18 to 45 Years Old |
Completed |
NCT05409196 |
Phase 1 |
Placebo |
6 |
A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg Daily or 550 mg Twice Daily) for Chemoprophylaxis Against Travelers' Diarrhea (TD) Among Active Duty Deployed U.S. and British Military Personnel |
Unknown status |
NCT02498301 |
|
Rifaximin;Placebo |
7 |
Double-Blind, Placebo-Controlled Study of Three-Month Treatment With the Combination of Ofloxacin and Roxithromycin in Recent-Onset Reactive Arthritis |
Completed |
NCT00621387 |
|
ofloxacin and roxithromycin;placebo |
8 |
Barriers and Facilitators of Flu, Pneumonia and SARS-CoV-2 (COVID-19) Vaccination in Adults With Inflammatory Conditions Treated With Immune-suppressing Drugs |
Completed |
NCT05115370 |
|
|
9 |
Late Cardial Assessment in Children Who Were Diagnosed With Post Streptococcal Reactive Arthritis - a Long Term Study |
Completed |
NCT01179451 |
|
|
10 |
A Bicentre Retrospective Study of Features and Outcomes of Patients With Reactive Arthritis |
Completed |
NCT03926429 |
|
|
11 |
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients |
Completed |
NCT00001679 |
|
|
12 |
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis |
Completed |
NCT00001375 |
|
|
13 |
Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers |
Recruiting |
NCT04751396 |
|
|
14 |
Rheumatology Patient Registry and Biorepository |
Recruiting |
NCT04402086 |
|
|
15 |
Exploring Patient and Healthcare Professional Views and Experiences of the Current and Recommended Monitoring Strategies for Inflammatory Conditions Treated With Commonly Used Immune Suppressing Drugs |
Recruiting |
NCT05458531 |
|
|
16 |
A Pilot Randomized Control Trial Testing the Acceptability and Feasibility of a Pediatric Interactive Relational Agent (PIRA) vs. Standard Preoperative Education |
Recruiting |
NCT04586569 |
|
|
|